Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143K Buy
396
+97
+32% +$33.2K 0.04% 128
2026
Q1
$105K Buy
299
+2
+0.7% +$713 0.04% 135
2025
Q4
$97.2K Buy
297
+113
+61% +$35.8K 0.03% 136
2025
Q3
$51.9K Hold
184
– – 0.01% 165
2025
Q2
$51.4K Buy
184
+5
+3% +$1.42K 0.02% 165
2025
Q1
$55.8K Buy
179
+4
+2% +$1.18K 0.02% 155
2024
Q4
$45.6K Buy
+175
New +$51.9K 0.01% 153

Other funds holding AMGN

S&T Bank's AMGN Position: Q2 2026 in Review

S&T Bank increased its Amgen (AMGN) stake by 32% in Q2 2026, buying an estimated $33.2K and bringing the position to 396 shares worth $143K. The position accounts for 0.04% of the portfolio, ranked #128.

S&T Bank first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • S&T Bank held 396 shares of Amgen worth $143K as of Q2 2026.
  • S&T Bank bought 97 Amgen shares in Q2 2026, an estimated $33.2K.
  • Amgen made up 0.04% of S&T Bank's portfolio in Q2 2026, its #128 holding.
  • S&T Bank first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.